Latest News about Premium
Recent news which mentions Premium
This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape
April 10, 2024
From Benzinga
Curated Strains And Branded Cannabis Gear By The Cannabist And Revelry Launching In Four East Coast Markets
April 10, 2024
From Benzinga
Female-Led California Weed Co. Gold Flora's Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit
April 05, 2024
From Benzinga
This Canadian Company Emerges Among Cannabis Giants As German Weed Legalization Goes Into Effect
March 25, 2024
From Benzinga
From Benzinga
SNDL Reports Record CA$909M In Net Revenue For 2023, CEO Zach George Calls It 'Foundational' Period
March 21, 2024
From Benzinga
Aurora Cannabis Earns Coveted GMP Certification For Australian Market, Here's What It Means
March 20, 2024
From Benzinga
New York Weed Giant Cannabist To Complete Nearly $26M Private Placement Offering Of Convertible Debentures
March 15, 2024
From Benzinga
Nextleaf's Alberta Debut Results In 170% YoY Net Revenue Surge In Q1, Here's What's Next For The Cannabis Co.
March 04, 2024
From Benzinga
Aurora Cannabis Bounces Back: Debt Paid, Growth Ahead
March 01, 2024
From Benzinga
Craft Cannabis Co. Grown Rogue Reports Gross Profit Increase In 2023, CEO Signals Expansion
February 29, 2024
From Benzinga
Restructuring Plan Pays Off For Ancillary Cannabis Co. Despite YoY Net Sales Drop In Q4
February 29, 2024
From Benzinga
Canadian Cannabis Extractor Ayurcann's Q2 Revenue Jumps Over 81% YoY, Net Loss Grows
February 28, 2024
From Benzinga
From Benzinga
Heritage Cannabis Co. Boosts Gross Margin Over 50% In 2023 Thanks To This Smart Move
February 27, 2024
From Benzinga
EXCLUSIVE: Shifting Public Perception Of Cannabis Industry, AI's Role, More Insights From Market Leaders
February 26, 2024
Tickers
X
From Benzinga
DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs
February 23, 2024
From Benzinga
Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments
February 23, 2024
From Benzinga
From Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
From Benzinga
The Cannabist Company Attacks Debt With Repurchasing Agreement To Reduce Leverage By Up To $25M
January 23, 2024
From Benzinga
MLP M&A Monday: SUN Adding NuStar to Its Galaxy
January 22, 2024
From ETF Trends
Why Is My Screen So Green? Cannabis Stocks Surge In Early 2024, WTR Reports Findings
January 09, 2024
From Benzinga
Tilray Expands Weed Drink Selection, Here's What RIFF Brand Has In Store For Cannaseurs
January 04, 2024
From Benzinga
Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing
January 03, 2024
From Benzinga
Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal
January 02, 2024
From Benzinga
22nd Century Group Exits Cannabis Industry, Closes Franchise Sale Deal
December 29, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
